Recent Publications by Biovision GmbH: |  |
Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors--a proof of concept study.
Native peptides can be regarded as surrogate markers for protease activity... | 20th February, 2009
| Digilab BioVisioN GmbH, Feodor Lynen Str. 5, 30625 Hannover, Lower Saxony,
| Peptides. 2008 Dec;29(12):2188-95. Epub 2008 Aug 31.
DOI Direct Link |
In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma.
Dipeptidyl peptidase 4 (DPP4) inhibitors represent a novel class of oral... | 4th February, 2009
| Digilab BioVisioN GmbH, Hannover, Germany.
| Biochem Pharmacol. 2009 Jan 15;77(2):228-37. Epub 2008 Oct 1.
DOI Direct Link |
Specimen collection and handling: standardization of blood sample collection.
Preanalytical variables can alter the analysis of blood-derived samples.... | 24th May, 2008
| Digilab BioVision GmbH, Hannover, Germany.
| Methods Mol Biol. 2008;428:35-42.
|
Peptidomics analysis of human blood specimens for biomarker discovery.
This review addresses the concepts, limitations and perspectives for the... | 12th October, 2007
| Digilab BioVisioN GmbH, Feodor-Lynen-Str. 5, 30625 Hannover, Germany.
| Expert Rev Mol Diagn. 2007 Sep;7(5):605-13.
DOI Direct Link |
Oncopeptidomics--a commentary on opportunities and limitations.
Cancer cells exhibit specific changes in protein expression and... | 5th June, 2007
| Digilab BioVisioN GmbH, Feodor-Lynen-Str. 5, 30625 Hannover, Germany.
| Cancer Lett. 2007 Apr 28;249(1):80-6. Epub 2007 Jan 31.
DOI Direct Link |
→View more Biovision GmbH research publications. |
This page has been viewed 231 times since April 2007, the link to the organisation's website has been followed 29 times
